Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
Andrew Cheng

Andrew Cheng

Chief executive, president and chairman of Avere Therapeutics

Appears in 1 story

Notable Quotes

"We have a clear line of sight to potentially value-generating clinical data and resources to execute our plans." — Andrew Cheng

Stories

Ex-Akero team takes an oral IL-23 pill public through NextCure merger

Money Moves

Set to lead the combined company after closing

The team that built Akero Therapeutics and sold it to Novo Nordisk for up to $5.2 billion has a second act. On Tuesday, their new startup, Avere Therapeutics, agreed to merge with struggling public biotech NextCure and raised $320 million to fund it.

Updated 1 hour ago